Stability Indicating LC-MS Method Development and Validation for the Study of the Forced Degradation Behavior of Pimobendan Drug

被引:0
作者
Gudapati, Atchuta Ramakrishna [1 ]
Pakalapati, Srinivasarao [1 ]
Rumalla, Chidananda Swamy [1 ]
Tammina, Benarji Patrudu [2 ]
机构
[1] GVK Biosci Pvt Ltd, Dept Med Chem, Hyderabad, Telangana, India
[2] Gitam Sch Sci, Dept Chem, Hyderabad 502329, Telangana, India
关键词
Pimobendan; Liquid Chromatography-Mass Spectrometry (LC-MS); Method Validation; Degradation compounds; Stability study; Quantification;
D O I
10.5330/ijpi.2020.4.91
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Analytical methods are necessary for the field of pharmaceuticals to discover the drug, determination of drugs and metabolites in biological matrices. The present study aimed to develop liquid chromatography-tandem mass spectrometry (LC-MS) and validation for quantification of Pimobendan in the formulation. Methods: The mobile phase composition was methanol, acetonitrile and 0.1 M phosphate buffers in the ratio of 45:15:40 (v/v) mixtures with isocratic elution. Prontosil ODS C-18 column (250 x 4.6 mm, 5 mu) was selected for separation with 264nm of LC UV detector wavelength. Ionization mass spectrophotometer was analyzed at nitrogen gas flow at 300 Psi and 300 degrees C of source temperature. Mass spectrometry analysis of Pimobendan drug fragments was performed by introducing column eluting into equipment for Q1 and MS scan. Results: The drug was eluted at 3.56 min retention and the calibration curve was achieved at 0.5-250 mu g/ml standard concentration. Different parameters of validation (linearity, specificity, precision, accuracy, selectivity and robustness) were performed and results confirm that all the parameters are in the acceptable limit. In the electrospray ionization spectra of Pimobendan [M+H], positive ions were observed at an m/z value of 335.42. The product-ions of 335.42 were observed at m/z value of 319.18, 287.19, 277.09, 261.08, 250.16, 223.30, 111.47 and 86.05. Conclusion: The proposed method is successfully achieved the acceptance criteria of all validation parameters and stability studies.
引用
收藏
页码:526 / 530
页数:5
相关论文
共 16 条
[1]  
[Anonymous], 1996, INT C HARM
[2]  
[Anonymous], 2005, Validation of Analytical Procedures: Text and Methodology
[3]   SIMULTANEOUS DETERMINATION OF THE ENANTIOMERS OF PIMOBENDAN AND ITS MAIN METABOLITE IN RAT PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ASAKURA, M ;
NAGAKURA, A ;
TARUI, S ;
MATSUMURA, R .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 614 (01) :135-141
[4]   A PRACTICAL APPROACH TO METHOD VALIDATION IN PHARMACEUTICAL ANALYSIS [J].
CARR, GP ;
WAHLICH, JC .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (8-12) :613-618
[5]  
Chaimbault P., 2014, RECENT ADV REDOX ACT, P31, DOI DOI 10.1007/978-94-017-8953-0_3
[6]  
Dass, 2017, HYPHENATED SEPARATIO, P151
[7]  
Dobariya TD, 2013, INT J CHEMTECH RES, V5, P2154
[8]  
GALATULAS I, 1990, Acta Physiologica Hungarica, V75, P123
[9]   Pimobendan in heart failure therapy - A silver bullet? [J].
Gordon, Sonya G. ;
Miller, Matthew W. ;
Saunders, Ashley B. .
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2006, 42 (02) :90-93
[10]   Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease:: The QUEST study [J].
Haggstrom, J. ;
Boswood, A. ;
O'Grady, M. ;
Joens, O. ;
Smith, S. ;
Swift, S. ;
Borgarelli, M. ;
Gavaghan, B. ;
Kresken, J. -G. ;
Patteson, M. ;
Ablad, B. ;
Bussadori, C. M. ;
Glaus, T. ;
Kovacevic, A. ;
Rapp, M. ;
Santilli, R. A. ;
Tidholm, A. ;
Eriksson, A. ;
Belanger, M. C. ;
Deinert, M. ;
Little, C. J. L. ;
Kvart, C. ;
French, A. ;
Ronn-Landbo, M. ;
Wess, G. ;
Eggertsdottir, A. V. ;
O'Sullivan, M. L. ;
Schneider, M. ;
Lombard, C. W. ;
Dukes-McEwan, J. ;
Willis, R. ;
Louvet, A. ;
DiFruscia, R. .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2008, 22 (05) :1124-1135